Floatz logo

Ringer'S Acetate

Large Intestine Disorder

Joachim ZdolsekUNKNOWNPhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Large Intestine Disorder cohort.

Same molecule, other indications

Ringer'S Acetate is also rated in:

benign neoplasmActive
BB
Indicative · Phase 4
65 / 100
View asset →
female reproductive organ cancerActive
B
Indicative · Phase 4
62 / 100
View asset →
colorectal cancerActive
CCC
Indicative · Phase 4
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →